{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:16:14Z","timestamp":1693642574870},"reference-count":35,"publisher":"Wiley","issue":"3-4","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"vor","delay-in-days":5418,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The peripheral T\u2010cell lymphomas of 50 patients were classified by histological type and tumour cell size, the latter as described by the Nebraska Group. There was no difference in the pattern of their clinical features among the various histological subtypes and their clinical outcome was similar. Cell size and other factors including sex, age, presence of B symptoms, sites of primary disease, histological subtypes according to the Japanese classification, lactate dehydrogenase level and presence of bulky disease did not appear to correlate with clinical outcome. However, patients with stage IV disease had significantly lower CR rate (9\/29 versus 16\/21, <jats:italic>p<\/jats:italic> = 0\u00b701) and poorer survival at 3 years (<jats:italic>p<\/jats:italic> = 0\u00b705) than those with stage I, II and III disease. Patients receiving COPP, the less intensive chemotherapy regimen, appeared to have poorer clinical outcome but the difference observed was not statistically significant because of the number of patients in each subgroup.<\/jats:p>","DOI":"10.1002\/hon.2900100302","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T17:58:38Z","timestamp":1171907918000},"page":"135-140","source":"Crossref","is-referenced-by-count":6,"title":["The prognostic factors for peripheral T\u2010cell lymphomas"],"prefix":"10.1002","volume":"10","author":[{"given":"Raymond","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Loke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90148-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.1988.6.10.1584","article-title":"T\u2010cell lymphomas, immunological histological. clinical and therapeutic analysis of 63 cases","volume":"67","author":"Coiffier B.","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood.V67.6.1578.1578","article-title":"Clinical and phenotypic diversity of T\u2010cell lymphomas","volume":"67","author":"Horning S. J.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(83)80299-8"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/07357908409040316"},{"key":"e_1_2_1_9_2","first-page":"615","article-title":"Immunophenotypic and genotypic characterisation of diffuse mixed non\u2010Hodgkin's lymphomas","volume":"135","author":"Katzin W. E.","year":"1989","journal-title":"Am. J. Pathol."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.40.9.995"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900040107"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00313028609087563"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","unstructured":"Liang R. Todd D. Chan T. K. et al.Intensive chemotherapy for peripheral T\u2010cell lymphomas.Hematol. Oncol.1992 in press.","DOI":"10.1002\/hon.2900100305"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901015)66:8<1743::AID-CNCR2820660817>3.0.CO;2-W"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080306"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.5.750"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689703"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204887"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080304"},{"key":"e_1_2_1_20_2","first-page":"1860","article-title":"Report of the Committee on Hodgkin's disease staging","volume":"31","author":"Carbone P. P.","year":"1971","journal-title":"Cancer Res."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-73-6-881"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-4-417"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-6-757"},{"key":"e_1_2_1_25_2","first-page":"139","volume-title":"Cancer Clinical Trials, Methods and Practice","author":"Hoogstraten B.","year":"1984"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V72.2.436.436","article-title":"The prognostic significance of the immunotype in diffuse large cell lymphoma, a comparative study of T\u2010cell and B\u2010cell phenotype","volume":"72","author":"Lippman S. M.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.6.725"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19891015)64:8<1620::AID-CNCR2820640812>3.0.CO;2-6"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.7.1088"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.28.569"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1989.tb01704.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.1.57"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.6.986"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.8.1370"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<971::AID-CNCR2820650425>3.0.CO;2-B"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2900100302","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2900100302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:35:00Z","timestamp":1693604100000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2900100302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":35,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1002\/hon.2900100302"],"URL":"https:\/\/doi.org\/10.1002\/hon.2900100302","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}